Physician

Vinna R Denison, MD

According to 2025 Medicare claims, Vinna Denison, MD (NPI: 1366406258) practices family practice in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Christian, KY. This provider's primary affiliated billing organization is VINNA DENISON HUMPHRIES MD LLC (NPI: 1720002371; TIN: 481277655) and primary practice location at 42240-1806.

Denison's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 133 traditional Medicare patients, billed 2,075 HCPCS/CPT codes, and received $59,606 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,551 prescription claims across 421 beneficiaries totaling $285,909 in drug costs, led by Eliquis (Apixaban). DME data shows 29 claims. Open Payments data shows 1 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $100,338 and ending at $59,606. Concurrently, Part D prescription costs have risen steadily, from $250,020 to $285,909. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,377 and ending at $6,657.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	203	1,865	$100,338
2016	212	1,461	$94,376
2017	203	1,397	$63,308
2018	201	1,566	$66,406
2019	190	2,306	$75,196
2020	181	2,411	$72,937
2021	175	2,250	$87,661
2022	150	1,838	$65,971
2023	147	2,235	$72,014
2024	133	2,075	$59,606

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	198	4,836	$250,020
2016	201	4,285	$216,182
2017	208	3,688	$220,800
2018	199	3,536	$237,643
2019	191	3,122	$256,602
2020	223	3,743	$219,324
2021	233	3,874	$235,793
2022	248	4,310	$291,439
2023	427	4,516	$353,836
2024	421	4,551	$285,909

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	35	232	$4,626
2016	34	187	$5,183
2017	28	116	$1,820
2018	N/R	49	$714
2019	11	63	$872
2020	N/R	67	$1,018
2021	N/R	25	$852
2022	N/R	11	$2,224
2023	N/R	23	$2,357
2024	N/R	29	$365

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	92	202	$73
82274	Stool analysis for blood, by fecal hemoglobin determination by immunoassay	86	86	$16
96372	Injection of drug or substance under skin or into muscle	95	459	$9
81002	Urinalysis, manual test	90	119	$3
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	93	361	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	49	2,088	$40,047
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	124	1,272	$36,987
Ozempic	Semaglutide	26	1,064	$36,746
Shingrix	Varicella-Zoster Ge/As01b/Pf	92	1,180	$18,923
Jardiance	Empagliflozin	18	720	$14,287

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	12	$293
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	N	N/R	17	$72

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$30	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vinna R. Denison, MD?

Tedicare shows public-source Medicare data for Vinna R. Denison, MD (NPI 1366406258), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinna R. Denison, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vinna R. Denison, MD?

Vinna R. Denison, MD is linked to VINNA DENISON HUMPHRIES MD LLC (billing NPI 1720002371) in the available physician profile data.

Does Vinna R. Denison, MD have Open Payments data?

Vinna R. Denison, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.